Literature DB >> 8274154

Varicella-zoster virus thymidine kinase. Characterization and substrate specificity.

G B Roberts1, J A Fyfe, S A McKee, S G Rahim, S M Daluge, M R Almond, J L Rideout, G W Koszalka, T A Krenitsky.   

Abstract

The varicella-zoster virus (VZV) thymidine kinase (TK) EC 2.7.2.21) catalyzes the phosphorylation of many anti-VZV nucleosides. Purified, bacterially expressed VZV TK was characterized with regard to N-terminal amino acid sequence, pI value, pH optimum, metal ion requirement, phosphate donor and acceptor specificity, and inhibition by dTTP. Initial velocities of thymidine phosphorylation with variable MgATP concentrations fit a two-site model with apparent Km values for MgATP of 0.10 and 900 microM. dTTP was a noncompetitive inhibitor of thymidine phosphorylation but was competitive with MgATP. Phosphate donor and acceptor specificities of the bacterially expressed enzyme were indistinguishable from those of VZV TK purified from infected cells. Detailed studies of the nucleoside specificity with the bacterially expressed enzyme showed that, for a given sugar moiety, thymine nucleosides were the most efficient substrates followed by nucleosides of cytosine, uracil, adenine, and with some exceptions, guanine. For a given pyrimidine or purine (except guanine), 2'-deoxyribonucleosides were the most efficient substrates, followed by arabinosides, ribonucleosides, 2',3'-dideoxyribonucleosides, and the acyclic moiety of acyclovir.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274154     DOI: 10.1016/0006-2952(93)90611-y

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  A pseudoreceptor modelling study of the varicella-zoster virus and human thymidine kinase binding sites.

Authors:  P A Greenidge; A Merz; G Folkers
Journal:  J Comput Aided Mol Des       Date:  1995-12       Impact factor: 3.686

Review 2.  Comparative Analysis of the Simian Varicella Virus and Varicella Zoster Virus Genomes.

Authors:  Wayne L Gray
Journal:  Viruses       Date:  2022-04-19       Impact factor: 5.818

3.  Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.

Authors:  D M Lowe; W K Alderton; M R Ellis; V Parmar; W H Miller; G B Roberts; J A Fyfe; R Gaillard; P Ertl; W Snowden
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

4.  Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Authors:  Jessica Rose; Vincent C Emery; Deepali Kumar; Anders Asberg; Anders Hartmann; Alan G Jardine; Angelo A Bignamini; Atul Humar; Avidan U Neumann
Journal:  PLoS Pathog       Date:  2017-04-13       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.